The Goal Free Pdf
Egisto Chancellor
Today, the Division for Sustainable Development Goals (DSDG) in the United Nations Department of Economic and Social Affairs (UNDESA) provides substantive support and capacity-building for the SDGs and their related thematic issues, including water, energy, climate, oceans, urbanization, transport, science and technology, the Global Sustainable Development Report (GSDR), partnerships and Small Island Developing States. DSDG plays a key role in the evaluation of UN systemwide implementation of the 2030 Agenda and on advocacy and outreach activities relating to the SDGs. In order to make the 2030 Agenda a reality, broad ownership of the SDGs must translate into a strong commitment by all stakeholders to implement the global goals. DSDG aims to help facilitate this engagement.
Every year, the UN Secretary General presents an annual SDG Progress report, which is developed in cooperation with the UN System, and based on the global indicator framework and data produced by national statistical systems and information collected at the regional level.
Additionally, the Global Sustainable Development Report is produced once every four years to inform the quadrennial SDG review deliberations at the General Assembly. It is written by an Independent Group of Scientists appointed by the Secretary-General.
We're thrilled to announce that we'll soon be transitioning to a new website and membership software! This exciting change aims to enhance our organizational efficiency and ensure smoother operations moving forward. As we make this transition, we kindly ask for your patience, as there will be delays with GOAL memberships during the process. Starting June 7, 2024, we will not be able to accept ANY (online, via USPS, by phone, or in person), renewals or new memberships as we will be transferring all data to our new system. Please keep in mind this process may take up to 8 weeks.
On Friday, June 14, 2024 the Supreme Court of the United States (SCOTUS) issued its ruling in Garland v. Cargill. This particular case was a challenge to the Bureau of Alcohol Tobacco Firearms Explosives (BATFE) regulation banning bump stocks ...
To print out your GOAL membership card, sign into your GOAL online account via goal.org. Once you are in your profile you can then click Printable PDF and print. If you do not have access to a printer, email ang...@goal.org and she will get one out ASAP!
Achieving global health goals faces significant challenges, with progress slowing since 2015 in areas like maternal mortality, premature deaths from major noncommunicable diseases, and access to essential healthcare. Inequalities persist, especially among vulnerable populations, exacerbated by the climate crisis. To meet the SDG 3 targets by 2030, substantial investment and focus are needed to address these challenges, including tackling inequality and environmental factors. Urgent action is required to protect vulnerable groups and regions with high disease burdens.
Target 3.5: Global drug-related treatment coverage has decreased from approximately 11% in 2015 to under 9% in 2022. Alarmingly, treatment coverage for women consistently lags behind that for men across all regions. In 2022, over 13% of men with drug use disorders received treatment globally, while less than 6% of women did. Moreover, data on treatment coverage for alcohol use disorders vary widely, ranging from a mere 0.3% to a maximum of 14% in reporting countries.
Target 3.8: The proportion of the population not covered by essential health services decreased by about 15% between 2000 and 2021, with minimal progress made after 2015. In 2021, about four and a half billion people were not covered by essential health services.
Target 3.c: While a recent study shows that the projected global shortage of health workers by 2030 has reduced from 18 million to 10 million, the aging of the population induces an increased health need and further widens this gap. An additional 1.8 million health workers are needed in fifty-four countries (mostly from high-income countries) just to maintain the current age-standardized density of health workers.
The pandemic and other ongoing crises are hindering progress in achieving SDG3, exacerbating existing health inequalities and threatening progress towards universal health coverage. As a result, 68 million children are known to be un- or under-vaccinated as of 2022 from TB and malaria increased. This has been particularly challenging in low- and middle-income countries, where health systems were already under-resourced before the pandemic. The pandemic has also highlighted the need for stronger global health security systems to prevent and respond to future pandemics. Overcoming these setbacks and dealing with longstanding shortcomings in health-care provision requires an urgent strengthening of health systems.
An estimated 1.5 million new HIV infections and 680,000 deaths from AIDS-related causes occurred in 2020. The incidence of HIV infections globally declined by 39 per cent between 2010 and 2020, far less than the 75 per cent target agreed by the General Assembly in 2016. Measures to slow the spread of the COVID-19 pandemic and the additional strain the new pandemic has placed on health systems have disrupted HIV-related services.
There were an estimated 241 million malaria cases and 627,000 malaria deaths worldwide in 2020. This represents about 14 million more cases in 2020 compared with 2019 and 69,000 more deaths. About two thirds of the additional deaths were linked to disruptions in the provision of malaria services during the pandemic. Africa was home to 95 per cent of malaria cases and 96 per cent of malaria deaths.
Despite significant disruptions to health services caused by the COVID-19 pandemic, the global number of people requiring treatment and care for neglected tropical diseases decreased from 2.19 billion in 2010 to 1.73 billion in 2020. Notably, 48 per cent of the total population of least developed countries, required treatment and care for neglected tropical diseases in 2020, down from 79 per cent in 2010.
Globally, 74 per cent of all deaths in 2019 were caused by non-communicable diseases. The probability of dying from any of the four main non-communicable diseases (cardiovascular disease, cancer, diabetes or chronic respiratory disease) between 30 and 70 tears of age declined from 19.9 per cent in 2010 to 17.8 per cent in 2019. This rate of decline is insufficient to meet the Sustainable Development Goal target.
Tobacco use rates have declined in 150 countries, contributing to the decline of the global average prevalence rate from 24.4 per cent in 2015 to 22.3 per cent in 2020. In 15 countries, tobacco use rates are either steady or still going up.
The global suicide death rate declined by 29 per cent from 13.0 deaths per 100,000 population in 2000 to 9.2 deaths per 100,000 in 2019. Although the available data do not show an increase in suicide rates during the first months of the COVID-19 crisis, the pandemic has had a severe impact on the mental health and well-being of people around the world. In 2020, there was a 25 per cent increase in the prevalence of anxiety and depression worldwide.
Before the COVID-19 pandemic, progress had been made in many health areas, including improving the health of mothers and children, increasing immunization coverage and reducing the incidence of communicable diseases, albeit not fast enough to meet the Goal 3 targets by 2030. The disruption caused by the pandemic has now halted progress and even reversed some gains made. According to a recent survey, substantial disruptions persist more than a year into the pandemic, with about 90 per cent of countries and territories still reporting one or more disruptions to essential health services. Among the health services most extensively affected are those for mental, neurological and substance use disorders; neglected tropical diseases; tuberculosis; HIV and hepatitis B and C; cancer screening; services for other non-communicable diseases, including hypertension and diabetes; family planning and contraception; urgent dental care; malnutrition; immunization; and malaria.
The world has made substantial progress towards the goal of ending preventable child deaths, with the global under-5 mortality rate decreasing from 76 to 38 deaths per 1,000 live births between 2000 and 2019. The global neonatal mortality rate fell from 30 deaths to 17 per 1,000 live births in the same period. Even with such progress, 5.2 million children died in 2019 before reaching their fifth birthday, with almost half of those deaths, 2.4 million, occurring in the first month of life. While the full impact of the pandemic on child survival is not yet known, significant disruption to the continued provision of life-saving interventions could stall or even reverse the progress made.
While the rate of new HIV infections declined from 0.48 infections pe r 1,000 uninfected population among adults (15 to 49 years of age) to 0.37 per 1,000 between 2010 and 2019, it remained far higher than the global target for 2020. The largest decrease was in sub-Saharan Africa, the region with the highest numbers of people living with HIV. Major inequalities remain in access to HIV prevention, testing and treatment services across regions, countries, and sub-populations within countries. There is evidence to suggest that the COVID-19 pandemic has caused considerable disruption to HIV services, including testing, initiation of treatment, voluntary medical male circumcision and pre-exposure prophylaxis.
In 2019, an estimated 10 million people fell ill with tuberculosis, of whom 56 per cent were adult men, 32 per cent adult women, 12 per cent children and 8.2 per cent people living with HIV, making it the leading cause of death from a single infectious agent. Globally, the incidence of tuberculosis fell from 174 new and relapse cases per 100,000 population in 2000 to 130 cases per 100,000 in 2019, a 25 per cent decline over the period, with the tuberculosis mortality rate among HIV-negative people falling by 45 per cent in the same period. Although the disease burden is decreasing, large gaps in detection and treatment persist, and the current pace of progress is not fast enough to meet the target of ending tuberculosis by 2030. Drug - resistant tuberculosis is a continuing threat: in 2019, there were 465,000 new cases with resistance to rifampicin, the most effective first-line drug, and 78 per cent of those infected with tuberculosis had a multidrug-resistant strain. As a result of the COVID-19 pandemic, an estimated 1.4 million fewer people received necessary care for tuberculosis during 2020 compared with the previous year, a reduction in treatment levels of 21 per cent.
c80f0f1006